Why are Dr. Reddy’s shares trading higher today
Dr. Reddy’s Laboratories has received the U.S. FDA approval to launch Fesoterodine Fumarate extended-release tablets in the American market
us fda
July 2022
November 2021
November 2017
Competitors Within
Home-grown smaller players are giving biggies a run for their money in the US generics market.
US business remains Sun Pharma’s weak spot
US sales have dropped to less than a third of overall revenue from nearly half five years ago and profits have taken a beating despite cost synergies after the acquisition of Ranbaxy Laboratories.
